ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	33212090	V317M	BALF2	BALF2	Cholangiocarcinoma	R S L	View
2	33212090	E1065G	BALF2	BALF2	Cholangiocarcinoma	R S L	View
3	35902864	I613V	BALF2	BALF2	Nasopharyngeal Carcinoma	G R S	View
4	35902864	V317M	BALF2	BALF2	Nasopharyngeal Carcinoma	G R S	View
5	35902864	V700L	BALF2	BALF2	Nasopharyngeal Carcinoma	G R S	View
6	35902864	C162215A	BALF2	BALF2	Nasopharyngeal Carcinoma	G R S	View
7	35902864	C162476T	BALF2	BALF2	Nasopharyngeal Carcinoma	G R S	View
8	35902864	C163364T	BALF2	BALF2	Nasopharyngeal Carcinoma	G R S	View
9	35902864	G163287A	BALF2	BALF2	Nasopharyngeal Carcinoma	G R S	View
10	35902864	C162507T	BALF2	BALF2	Nasopharyngeal Carcinoma	G R S	View
11	35902864	G162852T	BALF2	BALF2	Nasopharyngeal Carcinoma	G R S	View
12	39024697	I1613V	BALF2	BALF2	Nasopharyngeal Carcinoma	G R S	View
13	39024697	V317M	BALF2	BALF2	Nasopharyngeal Carcinoma	G R S I	View
14	39024697	T162476C	BALF2	BALF2	Nasopharyngeal Carcinoma	G R S	View
15	39024697	C163364T	BALF2	BALF2	Nasopharyngeal Carcinoma	G R S I	View
16	37310118	I613V	BALF2	BALF2	Nasopharyngeal Carcinoma	I C L	View
17	31209392	C162215A	BALF2	BALF2	Nasopharyngeal Carcinoma	R S L	View
18	31209392	T162476C	BALF2	BALF2	Nasopharyngeal Carcinoma	R S L	View
19	31209392	C162507T	BALF2	BALF2	Nasopharyngeal Carcinoma	R S L	View
20	31209392	G162852T	BALF2	BALF2	Nasopharyngeal Carcinoma	R S L	View
21	31209392	C163364T	BALF2	BALF2	Nasopharyngeal Carcinoma	R S L	View
22	31209392	A7048C	BALF2	BALF2	Nasopharyngeal Carcinoma	R S L	View
23	31209392	V700L	BALF2	BALF2	Nasopharyngeal Carcinoma	R S L	View
24	31209392	I613V	BALF2	BALF2	Nasopharyngeal Carcinoma	R S L	View
25	31209392	V317M	BALF2	BALF2	Nasopharyngeal Carcinoma	R S L	View
26	34567789	V317M	BALF2	BALF2	Nasopharyngeal Carcinoma	G R S C L	View
27	31481499	E1065G	BALF2	BALF2	Nasopharyngeal Carcinoma		View
28	31481499	I613V	BALF2	BALF2	Nasopharyngeal Carcinoma		View
29	31481499	S1093G	BALF2	BALF2	Nasopharyngeal Carcinoma		View
30	31481499	V317E	BALF2	BALF2	Nasopharyngeal Carcinoma		View
31	31481499	V700L	BALF2	BALF2	Nasopharyngeal Carcinoma		View
32	31481499	V317M	BALF2	BALF2	Nasopharyngeal Carcinoma Stomach Neoplasms		View
33	34908446	T161036C	BALF2	BALF2	Pulmonary Lymphoepithelioma-Like Carcinoma	G R S C L	View
34	34908446	S1093G	BALF2	BALF2	Pulmonary Lymphoepithelioma-Like Carcinoma	G R S C L	View
35	34908446	C163364T	BALF2	BALF2	Pulmonary Lymphoepithelioma-Like Carcinoma	G R S C L	View
36	34908446	V317M	BALF2	BALF2	Pulmonary Lymphoepithelioma-Like Carcinoma	G R S C L	View
37	34908446	G163464A	BALF2	BALF2	Pulmonary Lymphoepithelioma-Like Carcinoma	G R S C L	View

Contents
Description

The table shows all curated mutation sites of EBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.